Will Glenmark’s COVID-19 drug give it a new lease of life or just a short energy boost?
The pharma major has taken a different path from peers, in launching a new drug instead of inking a licensing deal
Shruti Venkatesh - July 04, 2020
Gaurav Parikh
Jeena Scriptech's MD believes land bank-rich Bombay Dyeing is a mispricing opportunity begging to be pounced upon
April 24, 2019
Gaurav A Parikh
Jeena Scriptech's managing director feels HOV Services’ price does not capture the value of its US investment
December 14, 2017
Spot the winner
In a market that swung from extremes, the 13 stocks recommended for 2016 ended up displaying shocking to amazing returns
January 13, 2017
Gaurav A Parikh
There is a potential for non-linear profitability if Ruby Mills gets to develop its surplus land and increase occupancy at 'The Ruby' tower
January 13, 2017
Very naughty idea, sirji
No one but the promoter seems to want the Grasim-AB Nuvo merger
Jitendra Kumar Gupta - August 13, 2016
Bagging rights
Jeena Scriptech's Gaurav Parikh reviews Christopher Mayer's 100 Baggers
May 20, 2016
Gaurav Parikh
Gaurav Parikh of Jeena Scriptech Alpha Advisors articulates the changing fortunes of Astec LifeSciences
Gaurav Parikh - December 09, 2015
Turning gold to dust
Jeena Scriptech Alpha Advisors' managing director Gaurav Parikh reviews Neil Irwin's The Alchemist
June 12, 2015
Gaurav Parikh
Jeena Scriptech Alpha Advisors' co-founder is happy to be wrong about film content major Shemaroo
May 11, 2015